Skip to main content

5 Result(s)

within M-A Belaud-Rotureau Remove this filter

and

  1. No Access

    Article

    Gene dosage effects in 46, XY DSD: usefulness of CGH technologies for diagnosis

    S. Jaillard, A. Bashamboo, L. Pasquier… in Journal of Assisted Reproduction and Genet… (2015)

  2. Article

    Open Access

    Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?

    The growth factor Angiotensin-2 signals through Angiotensin receptor type 1 (AT1-R) in a broad range of cell types and tumours and through the type-2 receptor (AT2-R) in a more restricted group of cell types. ...

    T Dolley-Hitze, F Jouan, B Martin, S Mottier, J Edeline… in British Journal of Cancer (2010)

    Download PDF (1067 KB) View Article

  3. No Access

    Article

    EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemia

    T Leguay, C Foucaud, M Parrens, O Fitoussi, K Bouabdallah, M A Belaud-Rotureau… in Leukemia (2007)

  4. No Access

    Article

    Early transitory rise in intracellular pH leads to Bax conformation change during ceramide-induced apoptosis

    Ceramide can induce apoptosis through a caspase independent pathway. Bax has been described as able to kill cells in the absence of caspase activity, therefore we measured Bax in situ during ceramide-induced apop...

    M.A. Belaud-Rotureau, N. Leducq, F. Macouillard Poulletier de Gannes… in Apoptosis (2000)

  5. No Access

    Article

    Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment

    Anthracyclines trigger an apoptotic cell death but their molecular targets are not totally explored. We investigated the apoptotic response of blast cells and lymphocytes from medullary samples of 31 de novo acut...

    M-A Belaud-Rotureau, F Durrieu, G Labroille, F Lacombe, O Fitoussi, P Agape… in Leukemia (2000)